SEC FORM 5

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0362
Estimated average burden
hours per response:			1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

BEPLATE DOUGLAS K

(Last)

(First)

(Middle)

C/O UNITED HEALTH PRODUCTS, INC.

10624 S. EASTERN AVE., STE. A209

(Street)

HENDERSON

89052

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
United Health Products, Inc. [ UEEC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2018

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	01/10/2018		G4	150,000	D	$0.00⁽²⁾	4,740,253	D
Common Stock⁽¹⁾	04/10/2018		G4	200,000	D	$0.00⁽²⁾	4,540,253	D
Common Stock⁽¹⁾	04/18/2018		G4	225,253	D	$0.00⁽²⁾	4,365,000	D
Common Stock⁽¹⁾	05/04/2018		S4	148,653	D	$0.69	4,216,447	D
Common Stock⁽¹⁾	06/14/2018		W4	1,512,000	A	$0.00⁽³⁾	5,728,447	D
Common Stock⁽¹⁾	06/14/2018		G4	46,750	D	$0.00⁽²⁾	5,681,697	D
Common Stock⁽¹⁾	07/10/2018		G4	243,650	D	$0.00⁽²⁾	5,438,047	D
Common Stock⁽¹⁾	08/06/2018		S4	300,000	D	$0.33	5,138,047	D
Common Stock⁽¹⁾	09/17/2018		G4	1,000,000	D	$0.00⁽²⁾	4,138,047	D
Common Stock⁽¹⁾	10/25/2018		G4	240,000	D	$0.00⁽²⁾	3,898,047	D
Common Stock⁽¹⁾	10/31/2018		G4	100,000	D	$0.00⁽²⁾	3,798,047	D
Common Stock⁽¹⁾	11/29/2018		S4	400,000	D	$0.5	3,398,047	D
Common Stock⁽¹⁾	12/11/2018		S4	90,000	D	$0.5	3,308,047	D
Common Stock⁽¹⁾	12/17/2018		S4	555,000	D	$0.5	2,753,047	D
Common Stock⁽¹⁾	12/17/2018		G4	40,000	D	$0.00⁽²⁾	2,713,047	D
Common Stock⁽¹⁾	12/19/2018		G4	209,000	D	$0.00⁽²⁾	2,504,047	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Excludes shares of common stock owned by his spouse and other adult family members.

2. Shares were gifted and no price per share was received by Mr. Beplate.

3. Shares were inherited from his stepdad.

Remarks:

	/s/ Douglas Beplate	11/05/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.